The biomed company was founded by Prof. Ruth Arnon. The results of the company’s trial did not show a significant difference between the group of patients treated with the BiondVax vaccine and the group treated with the placebo
Calcalist service 09:3924.10.20
Read more in Calcalist:
The results did not show a significant difference between the group of patients treated with the BiondVax vaccine and the group treated with the placebo. BiondVax CEO Ron Babakov did not hide his feelings: “We are disappointed with the result and thank all the staff at the company that has been with us for 15 years. We have made a joint effort to try and come up with an innovative solution to a global problem. ”
BiondVax was established on the basis of a groundbreaking scientific idea by one of the best-known scientists in Israel, Prof. Ruth Arnon. Arnon is the bride of the Israel Prize, was the president of the Israeli National Academy of Sciences, and one of the developers of the Copaxone drug for Teva’s multiple sclerosis.
Shares of BiondVax fell to $ 5.2 – before the announcement stood at $ 37.
Tamar Ben Yedidya, Ron Babakov Photo: BiondVax
*The article has been translated based on the content of Source link by https://www.calcalist.co.il/markets/articles/0,7340,L-3864971,00.html
. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.
*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!
These were the details of the news BiondVax plunged 86 percent in New York after the failure of... for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at news1.news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.